Pancreatic carcinoma, familial
|
0.390 |
GeneticVariation
|
disease |
BEFREE |
PALB2 gene is mutated in about 1-2% of familial breast cancer as well as in 3-4% of familial pancreatic cancer cases.
|
25666743 |
2015 |
Pancreatic carcinoma, familial
|
0.390 |
GeneticVariation
|
disease |
BEFREE |
Germ-line DNA samples from 727 unrelated probands with positive family history (521 met criteria for familial pancreatic cancer) were tested in compliance with the Clinical Laboratory Improvement Amendments for mutations in BRCA1 and BRCA2 (including analysis of deletions and rearrangements), PALB2, and CDKN2A.
|
25356972 |
2015 |
Pancreatic carcinoma, familial
|
0.390 |
GeneticVariation
|
disease |
BEFREE |
Germline mutations in PALB2 have been identified in approximately 1% of familial breast cancer and 3-4% of familial pancreatic cancer.
|
23935836 |
2013 |
Pancreatic carcinoma, familial
|
0.390 |
GeneticVariation
|
disease |
BEFREE |
Exome sequencing identifies nonsegregating nonsense ATM and PALB2 variants in familial pancreatic cancer.
|
23561644 |
2013 |
Pancreatic carcinoma, familial
|
0.390 |
GeneticVariation
|
disease |
BEFREE |
Routine testing for PALB2 mutations in familial pancreatic cancer families and breast cancer families with pancreatic cancer is not indicated.
|
22166947 |
2012 |
Pancreatic carcinoma, familial
|
0.390 |
SusceptibilityMutation
|
disease |
ORPHANET |
Germline mutations in PALB2 have been identified in approximately 1-2% of familial breast cancer and 3-4% of familial pancreatic cancer cases.
|
21365267 |
2011 |
Pancreatic carcinoma, familial
|
0.390 |
GeneticVariation
|
disease |
BEFREE |
Germline mutations in PALB2 have been identified in approximately 1-2% of familial breast cancer and 3-4% of familial pancreatic cancer cases.
|
21365267 |
2011 |
Pancreatic carcinoma, familial
|
0.390 |
GeneticVariation
|
disease |
BEFREE |
Mono-allelic germline mutations of BRCA2 and PALB2 are risk alleles of female breast cancer and have also been reported in familial pancreatic cancer, and bi-allelic mutations cause a severe form of Fanconi anemia.
|
20582465 |
2011 |
Pancreatic carcinoma, familial
|
0.390 |
GeneticVariation
|
disease |
BEFREE |
PALB2 mutations in European familial pancreatic cancer families.
|
20412113 |
2010 |
Pancreatic carcinoma, familial
|
0.390 |
SusceptibilityMutation
|
disease |
ORPHANET |
PALB2 mutations in European familial pancreatic cancer families.
|
20412113 |
2010 |
Pancreatic carcinoma, familial
|
0.390 |
GeneticVariation
|
disease |
BEFREE |
Analysis of 96 additional patients with familial pancreatic cancer revealed three distinct protein-truncating mutations, thereby validating the role of PALB2 as a susceptibility gene for pancreatic cancer.
|
19264984 |
2009 |